Allogene Therapeutics, Inc.
ANTIBODIES AGAINST 4G7-DERIVED CHIMERIC ANTIGEN RECEPTORS

Last updated:

Abstract:

Provided herein are isolated antibodies that specifically bind anti-CD19 chimeric antigen receptors (CARs) derived from a 4G7 scFv. Also provided are methods of making and using these isolated antibodies.

Status:
Application
Type:

Utility

Filling date:

17 Apr 2020

Issue date:

22 Oct 2020